Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes ADVANCE Collaborative Group New England journal of medicine 358 (24), 2560-2572, 2008 | 10257 | 2008 |
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy BM Brenner, ME Cooper, D De Zeeuw, WF Keane, WE Mitch, HH Parving, ... New England journal of medicine 345 (12), 861-869, 2001 | 9804 | 2001 |
Mechanisms of diabetic complications JM Forbes, ME Cooper Physiological reviews 93 (1), 137-188, 2013 | 3287 | 2013 |
A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease MA Pfeffer, EA Burdmann, CY Chen, ME Cooper, D De Zeeuw, ... New England Journal of Medicine 361 (21), 2019-2032, 2009 | 2487 | 2009 |
Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future SE Kahn, ME Cooper, S Del Prato The Lancet 383 (9922), 1068-1083, 2014 | 2298 | 2014 |
Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan … CE Mogensen, S Neldam, I Tikkanen, S Oren, R Viskoper, RW Watts, ... Bmj 321 (7274), 1440-1444, 2000 | 1651 | 2000 |
Elective surgery cancellations due to the COVID-19 pandemic: global predictive modelling to inform surgical recovery plans Journal of British Surgery 107 (11), 1440-1449, 2020 | 1558 | 2020 |
Oxidative stress as a major culprit in kidney disease in diabetes JM Forbes, MT Coughlan, ME Cooper Diabetes 57 (6), 1446-1454, 2008 | 1532 | 2008 |
The role of advanced glycation end products in progression and complications of diabetes SY Goh, ME Cooper The Journal of Clinical Endocrinology & Metabolism 93 (4), 1143-1152, 2008 | 1353 | 2008 |
Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia A El-Osta, D Brasacchio, D Yao, A Pocai, PL Jones, RG Roeder, ... The Journal of experimental medicine 205 (10), 2409-2417, 2008 | 1298 | 2008 |
Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL D De Zeeuw, G Remuzzi, HH Parving, WF Keane, Z Zhang, S Shahinfar, ... Kidney international 65 (6), 2309-2320, 2004 | 1251 | 2004 |
Effect of linagliptin vs placebo on major cardiovascular events in adults with type 2 diabetes and high cardiovascular and renal risk: the CARMELINA randomized clinical trial J Rosenstock, V Perkovic, OE Johansen, ME Cooper, SE Kahn, N Marx, ... Jama 321 (1), 69-79, 2019 | 1175 | 2019 |
Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes T Ninomiya, V Perkovic, BE De Galan, S Zoungas, A Pillai, M Jardine, ... Journal of the American Society of Nephrology 20 (8), 1813-1821, 2009 | 1160 | 2009 |
Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy D De Zeeuw, G Remuzzi, HH Parving, WF Keane, Z Zhang, S Shahinfar, ... Circulation 110 (8), 921-927, 2004 | 1042 | 2004 |
Diabetic kidney disease MC Thomas, M Brownlee, K Susztak, K Sharma, KAM Jandeleit-Dahm, ... Nature reviews Disease primers 1 (1), 1-20, 2015 | 1029 | 2015 |
Development of drought-resistant cultivars using physiomorphological traits in rice S Fukai, M Cooper Field Crops Research 40 (2), 67-86, 1995 | 957 | 1995 |
New-onset diabetes in Covid-19 F Rubino, SA Amiel, P Zimmet, G Alberti, S Bornstein, RH Eckel, ... New England Journal of Medicine 383 (8), 789-790, 2020 | 919 | 2020 |
Reduced bone mass in daughters of women with osteoporosis E Seeman, JL Hopper, LA Bach, ME Cooper, E Parkinson, J McKay, ... New England Journal of Medicine 320 (9), 554-558, 1989 | 911 | 1989 |
Can changes in canopy and/or root system architecture explain historical maize yield trends in the US corn belt? GL Hammer, Z Dong, G McLean, A Doherty, C Messina, J Schussler, ... Crop Science 49 (1), 299-312, 2009 | 890 | 2009 |
The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury? RE Gilbert, ME Cooper Kidney international 56 (5), 1627-1637, 1999 | 883 | 1999 |